WellTheory: $5M Funding & AI Autoimmune Tools
- WellTheory, a digital health company specializing in autoimmune disease care, has secured $5 million in funding to expand its reach and further develop its AI-driven platform.
- The latest funding round saw participation from Samsung Next, Opal Ventures, and Up2 Fund, along with existing investors Accel, OVO Fund, and BoxGroup.
- WellTheory's collaborative care model partners with patients' existing physicians, offering personalized plans focused on key lifestyle factors such as nutrition, sleep, stress management, and movement.
WellTheory accelerates its mission with a meaningful $5 million funding round, marking a pivotal moment for its AI-driven autoimmune care platform. This investment fuels the launch of Care Scribe and Care Hub, innovative AI tools designed to revolutionize care for conditions such as lupus and multiple sclerosis. The funding will accelerate expansion within employer and health plan markets. With a focus on personalized care plans, the company is already seeing extraordinary results. News Directory 3 reports on WellTheory’s commitment to creating a modern, integrated infrastructure. Discover what’s next as WellTheory continues to innovate within the autoimmune disease space.
WellTheory Raises $5M too Launch AI-powered Autoimmune Care Platform
Updated May 27, 2025
WellTheory, a digital health company specializing in autoimmune disease care, has secured $5 million in funding to expand its reach and further develop its AI-driven platform. The company,based in Atherton,California,also announced the launch of two new AI tools designed to streamline care for individuals with conditions like lupus,multiple sclerosis,and celiac disease.
The latest funding round saw participation from Samsung Next, Opal Ventures, and Up2 Fund, along with existing investors Accel, OVO Fund, and BoxGroup. This brings welltheory’s total funding to $12 million. The infusion of capital will support the company’s growth within the employer and health plan sectors, as well as accelerate the growth of its AI-powered care infrastructure for both providers and members seeking autoimmune disease treatment.
WellTheory’s collaborative care model partners with patients’ existing physicians, offering personalized plans focused on key lifestyle factors such as nutrition, sleep, stress management, and movement. The company provides video sessions, continuous expert messaging, and diagnostic services to both employers and health plans, aiming to improve autoimmune disease management.
The newly launched AI tools, Care Scribe and Care Hub, are designed to enhance the efficiency and personalization of care. Care Scribe transcribes member sessions, drafts follow-up notes, and generates care plans that providers can review and customize. Care Hub aggregates member data,session history,and lab results into a centralized platform.
“Care delivery for patients with autoimmune disease is incredibly complex — our team built these tools to help give our Care Team time back for what matters most: supporting our members,” said Claire Rudolph, co-founder and head of product at WellTheory.
Rudolph added that Care Hub and Care Scribe are part of WellTheory’s effort to build a modern infrastructure for autoimmune care, using intelligent, integrated systems to streamline tasks and enable more personalized support.
The announcement follows the release of an outcomes report last month, which highlighted the effectiveness of WellTheory’s care model. The report indicated that 81% of members experienced improved digestive symptoms, 55% reported reduced fatigue, and 45% reported less pain.
What’s next
Looking ahead, WellTheory plans to focus on building partnerships with employers and health plans, further investing in AI, and reducing administrative burdens for providers. The company also aims to develop new health programs, expanding on its existing women’s health program for hormonal conditions.